细胞激素市场：按类型、按治疗应用、按最终用户、按地区

细胞激素市场预计到2024年将达到908.4亿美元，预计到2031年将达到1,613.8亿美元，2024年至2031年的复合年增长率为8.6%。

图：2024 年按地区分類的细胞激素市场占有率(%)

细胞激素是细胞讯号蛋白，对于控制和调节免疫和发炎反应非常重要。细胞激素可作为免疫细胞之间的桥樑，介导或控制免疫和发炎，作为免疫反应的一部分。随着慢性发炎疾病、癌症和感染疾病的日益流行，用于诊断目的的细胞激素测定的需求显着增长。重组 DNA 技术的进步使得不同类型的细胞激素的大规模生产成为可能，促进了市场的成长。然而，在预测期内，与细胞激素研究相关的高成本可能会在一定程度上限制市场扩张。

市场动态：

慢性和危及生命的疾病盛行率的增加是推动细胞激素市场成长的主要因素。主要市场驱动因素包括全球癌症和感染疾病的增加。 2020年，全球癌症患者数将达1,930万，癌症死亡人数将达1,000万人。同样，COVID-19 和结核病等感染疾病正在增加对新诊断和治疗方法（包括细胞激素分析）的需求。此外，政府和私人组织增加细胞激素研究资金的倡议正在为市场参与者创造利润丰厚的机会。然而，细胞激素生产技术的高生产成本和技术限制继续阻碍市场潜力。细胞激素的保质期短和稳定性差也为更广泛的商业化带来了挑战。

本研究的主要特点

该报告详细分析了全球细胞激素市场，并提供了以 2023 年为基准年的预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它还揭示了各个细分市场的潜在商机，并说明了该市场中有吸引力的投资提案的矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球细胞激素市场的主要企业进行了分析。

本研究涵盖的主要企业包括 Abbott、AB Sciex、Agilent Technologies Inc.、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Quest Diagnostics Inc.、Danaher，其中包括 DiarinSo SpA 、免疫诊断系统和Fujirebio, Inc.

该报告的见解使负责人和公司经营团队能够就未来的产品发布、产品创新、市场扩张和行销策略做出明智的决策。

全球细胞激素市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过分析全球细胞激素市场时所使用的各种策略矩阵来促进他们的决策。

目录

第一章 分析目的与前提

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 企业合併(M&A) 场景

第 4 章细胞激素市场：按类型划分，2019-2031 年（十亿美元）

• 肿瘤坏死因子
• 白细胞介素-II
• 干扰素-IFN
• 表皮生长因子（EGF）
• 其他的

第五章细胞激素市场：依治疗应用分类，2019-2031（十亿美元）

• 癌症
• 气喘
• 关节炎
• 血液学
• 其他的

第六章细胞激素市场：以最终用户划分，2019-2031 年（十亿美元）

• 医院
• 实验室
• 其他的

第七章细胞激素市场：依地区划分，2019-2031（十亿美元）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• Abbott
• AB Sciex
• Agilent Technologies Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin SpA
• F.Hoffmann-La Roche Ltd.
• Quest Diagnostics Inc
• Danaher
• DiaSorin SpA
• Immunodiagnostic Systems
• Fujirebio, Inc.

第九章 分析师建议

• 《命运之轮》
• 分析师观点
• Coherent Opportunity Map (COM)

第10章 参考文献与调查方法

• 参考
• 分析方法
• 关于相干市场洞察

The cytokine market is estimated to be valued at USD 90.84 Bn in 2024 and is expected to reach USD 161.38 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Figure. Cytokine Market Share (%), By Region, 2024

Cytokines are cell-signalling proteins that are crucial for controlling and regulating immune responses and inflammatory reactions. They act as the bridge intermediaries between immune cells and mediate or regulate immunity and inflammation as part of immune response. With the increasing prevalence of chronic inflammatory diseases, cancer, and infectious diseases, the demand for cytokine assays for diagnostic purposes has been growing significantly. Advancements in recombinant DNA technology have enabled mass production of different types of cytokines, thus aiding market growth. However, high costs associated with cytokine research may restrain market expansion to some extent over the forecast period.

Market Dynamics:

Increasing incidence of chronic and life-threatening diseases is a key factor driving the cytokine market growth. Some of the major market drivers include rising cases of cancers and infectious diseases globally. , the global cancer burden has risen to 19.3 million cases and 10 million cancer deaths in 2020. Similarly, infectious diseases like COVID-19, tuberculosis, etc. have surged the need for new diagnostic and therapeutic approaches including cytokine profiling. Further, initiatives by governments and private organizations to increase funding for cytokine research present lucrative opportunities for market players. However, high production costs and technical limitations of cytokine production techniques continue to hamper market potential. Short shelf-life and poor stability of cytokines also challenge wider commercialization.

Key Features of the Study:

This report provides in-depth analysis of the global cytokine market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cytokine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, DiaSorin S.p.A, Immunodiagnostic Systems, Fujirebio, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global cytokine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cytokine market

Market Segmentation

• Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Tumor Necrosis Factor-TNF
  • Interleukins-II
  • Interferons-IFN
  • Epidermal Growth Factor-EGF
  • Others
• Therapeutic Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Cancer
  • Asthma
  • Arthritis
  • Hematology
  • Others
• End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Research laboratories
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • AB Sciex
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • Hoffmann-La Roche Ltd.
  • Quest Diagnostics Inc
  • Danaher
  • DiaSorin S.p.A
  • Immunodiagnostic Systems
  • Fujirebio, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Cytokine Market, By Type
  • Cytokine Market, By Therapeutic Application
  • Cytokine Market, By End User
  • Cytokine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Cytokine Market, By Type, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Tumor Necrosis Factor-TNF
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Interleukins-II
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Interferons-IFN
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Epidermal Growth Factor-EGF
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Cytokine Market, By Therapeutic Application, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Asthma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Cytokine Market, By End User, 2019-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Cytokine Market, By Region, 2019 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country/Region 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AB Sciex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F.Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Immunodiagnostic Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fujirebio, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us